
Respiratory Syncytial Virus (RSV) Pathophysiology
Respiratory syncytial virus (RSV) is a common and highly contagious virus that primarily affects the respiratory tract, particularly in infants and young children.1
This website contains promotional content and is intended for Healthcare Professionals based in the United States only.


Respiratory syncytial virus (RSV) is a common and highly contagious virus that primarily affects the respiratory tract, particularly in infants and young children.1
Why is it important to accurately measure factor VIII activity levels when treating patients with hemophilia A? Because the results can help you tailor treatment plans and help inform personalized treatment goals. To aid in shared decision-making, it’s essential for patients to understand the significance of factor VIII activity level assay measurements. This knowledge can empower them to actively participate in their treatment plan, make informed decisions, and improve their day-to-day lives and overall well-being.
Ensuring optimal care for patients with hemophilia A requires a thorough understanding of available treatment options, prioritization of bleed prevention and long-term joint health, and comprehensive patient education. This article will cover different types of factor VIII replacement therapies* and will compare an on-demand versus prophylactic treatment approach with the goal of helping tailor treatment plans effectively, which can help enhance quality of life.

A hub for healthcare professionals to discover and find information on our medicines and therapies


It's time to look at the bigger picture in hemophilia B
MAT-US-2405607-v1.0-06/2024